{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:18:05Z","timestamp":1788419885781,"version":"build-2803163510"},"reference-count":134,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.autrev.2018.11.007","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T16:47:33Z","timestamp":1554482853000},"page":"565-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease"],"prefix":"10.1016","volume":"18","author":[{"given":"Maria Sole","family":"Chimenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Alivernini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Tolusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Triggianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Conigliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gremese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.11.007_bb0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.autrev.2012.10.002","article-title":"Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways","volume":"12","author":"Chimenti","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0015","first-page":"210","article-title":"Psoriasis, psoriatic arthritis, or psoriatic disease?","volume":"33","author":"Scarpa","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3899\/jrheum.17666","article-title":"The sex influence on response to tumor necrosis factor-\u03b1 inhibitors and remission in axial spondyloarthritis","volume":"45","author":"Lubrano","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0025","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s10067-018-4209-9","article-title":"From autoinflammation to autoimmunity: old and recent findings","volume":"37","author":"Caso","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cei.12335","article-title":"Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment","volume":"177","author":"Conigliaro","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0035","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2018.11.007_bb0040","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00296-014-2956-8","article-title":"Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease?","volume":"34","author":"Perez-Alamino","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2018.11.007_bb0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/rheumatology\/ken456","article-title":"Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis","volume":"48","author":"Pasquetti","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.11.007_bb0050","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.autrev.2015.08.003","article-title":"Auto-reactions, autoimmunity and psoriatic arthritis","volume":"14","author":"Chimenti","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0055","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.autrev.2016.03.003","article-title":"Autoantibodies in inflammatory arthritis","volume":"15","author":"Conigliaro","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0060","article-title":"Crossreactive autoantibodies directed against cutaneous and joint antigens are present in psoriatic arthritis","volume":"16","author":"Dolcino","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.11.007_bb0065","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/ard.2006.062042","article-title":"Ectopic lymphoid neogenesis in psoriatic arthritis","volume":"66","author":"Ca\u00f1ete","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0070","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2018.11.007_bb0075","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2018.11.007_bb0080","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3389\/fimmu.2018.01936","article-title":"Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: new biomarkers in PsA","volume":"9","author":"Frasca","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0085","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.autrev.2011.04.017","article-title":"Emerging role for NK cells in the pathogenesis of inflammatory arthropathies","volume":"10","author":"Conigliaro","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2018.08.003","article-title":"Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis","volume":"18","author":"Giacomelli","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2230.1990.tb02011.x","article-title":"Complement activation in psoriasis","volume":"15","author":"Rosenberg","year":"1990","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.autrev.2011.04.012","article-title":"Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors","volume":"10","author":"Ballanti","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0105","first-page":"82","article-title":"Complement C3 cleavage product in synovial fluids detected by immunofixation","volume":"50","author":"Partsch","year":"1991","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0110","first-page":"23","article-title":"Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment","volume":"30","author":"Chimenti","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0115","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/hrt.2003.017327","article-title":"Up regulation of C3, C4, and soluble intercellular adhesion molecule-1 co-expresses with high sensitivity C reactive protein in familial hypoalphalipoproteinaemia: further evidence of inflammatory activation","volume":"90","author":"Sampietro","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.autrev.2018.11.007_bb0120","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/ard.2004.025585","article-title":"Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept","volume":"64","author":"Fiocco","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fmed.2018.00186","article-title":"Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: microRNA signature, histological, and ultrasound features","volume":"5","author":"Alivernini","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2018.11.007_bb0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/ard.2010.139550","article-title":"Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials","volume":"70","author":"van de Sande","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0135","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.38995","article-title":"Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis","volume":"67","author":"Belasco","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0140","first-page":"260","article-title":"Angiopoietins, growth factors, and vascular morphology in early arthritis","volume":"30","author":"Fearon","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0145","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/art.1780360705","article-title":"Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis","volume":"36","author":"Veale","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0150","doi-asserted-by":"crossref","first-page":"R569","DOI":"10.1186\/ar1698","article-title":"Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis","volume":"7","author":"Kruithof","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.11.007_bb0155","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.autrev.2014.01.050","article-title":"The IL-23\/IL-17 axis in psoriatic arthritis","volume":"13","author":"Suzuki","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0160","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/ard.2005.050963","article-title":"Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment","volume":"65","author":"van Kuijk","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0165","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/annrheumdis-2013-204229","article-title":"High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission","volume":"74","author":"Araujo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0170","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/annrheumdis-2016-210424","article-title":"Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?","volume":"76","author":"Alivernini","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0175","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.autrev.2018.04.002","article-title":"Nature versus nurture in the spectrum of rheumatic diseases: classification of spondyloarthritis as autoimmune or autoinflammatory","volume":"17","author":"Generali","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autrev.2016.09.015","article-title":"Are psoriasis and psoriatic arthritis the same disease? The IL-23\/IL-17 axis data","volume":"16","author":"Sakkas","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0185","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.clindermatol.2007.08.003","article-title":"The clinical spectrum of psoriasis","volume":"25","author":"Naldi","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3899\/jrheum.120243","article-title":"New developments in magnetic resonance imaging of the nail unit","volume":"89","author":"Soscia","year":"2012","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.autrev.2018.11.007_bb0195","first-page":"1315","article-title":"Nail and distal interphalangeal joint in psoriatic arthritis","volume":"33","author":"Scarpa","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0200","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2012-201706","article-title":"High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires","volume":"72","author":"Haroon","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0210","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archdermatol.2010.141","article-title":"Obesity in early adulthood as a risk factor for psoriatic arthritis","volume":"146","author":"Soltani-Arabshahi","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0215","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11926-015-0540-1","article-title":"Clinical risk factors for the development of psoriatic arthritis among patients with psoriasis: a review of available evidence","volume":"17","author":"Ogdie","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2018.11.007_bb0220","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3899\/jrheum.161402","article-title":"Psoriatic disease 10 years later","volume":"44","author":"Scarpa","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0225","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0230","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.semarthrit.2018.08.005","article-title":"Late onset psoriatic arthritis in a longitudinal cohort: Disease presentation, activity over time and prognosis","volume":"48","author":"Polachek","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0235","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.autrev.2015.05.010","article-title":"Measuring psoriatic disease in clinical practice. An expert opinion position paper","volume":"14","author":"Lubrano","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0240","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/art.39458","article-title":"Review: enthesitis: new insights into pathogenesis, diagnostic modalities, and treatment","volume":"68","author":"Kehl","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0245","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3899\/jrheum.130163","article-title":"Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era","volume":"40","author":"Gladman","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0250","first-page":"627","article-title":"Psoriatic arthritis","volume":"21","author":"Wright","year":"1971","journal-title":"Bull Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0255","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.2003.018184","article-title":"Dactylitis in psoriatic arthritis: a marker for disease severity?","volume":"64","author":"Brockbank","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0265","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11926-007-0074-2","article-title":"Axial disease in psoriatic arthritis","volume":"9","author":"Gladman","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2018.11.007_bb0270","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3899\/jrheum.150634","article-title":"The definition and measurement of axial psoriatic arthritis","volume":"93","author":"Lubrano","year":"2015","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.autrev.2018.11.007_bb0275","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/rheumatology\/keg445","article-title":"A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis\u2014\u2018DIP or not DIP revisited\u2019","volume":"42","author":"Kane","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.11.007_bb0280","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/1529-0131(200004)43:4<865::AID-ANR18>3.0.CO;2-W","article-title":"Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model","volume":"43","author":"Helliwell","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0285","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/rheumatology\/23.4.246","article-title":"Psoriatic arthritis in psoriatic patients","volume":"23","author":"Scarpa","year":"1984","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0290","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10067-016-3319-5","article-title":"Psoriatic nail involvement and its relationship with distal interphalangeal joint disease","volume":"35","author":"Lai","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/rheumatology\/keu328","article-title":"Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era","volume":"54","author":"McGonagle","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.11.007_bb0300","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3899\/jrheum.141545","article-title":"Psoriatic arthritis mutilans: clinical and radiographic criteria. A systematic review","volume":"42","author":"Haddad","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0305","first-page":"2638","article-title":"Clinical and genetic aspects of psoriatic arthritis \"sine psoriasis\"","volume":"30","author":"Scarpa","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0310","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/acr.23789","article-title":"Special Article: 2018 American College of Rheumatology\/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2018.11.007_bb0315","first-page":"1247","article-title":"The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982\u20131991","volume":"27","author":"Shbeeb","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0320","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/ard.2006.056457","article-title":"Predictors for radiological damage in psoriatic arthritis: results from a single centre","volume":"66","author":"Bond","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0325","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s002960100135","article-title":"Comparative analysis of psoriatic spondyloarthropathy between men and women","volume":"21","author":"Queiro","year":"2001","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2018.11.007_bb0330","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2012-201357","article-title":"Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis","volume":"72","author":"Eder","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0335","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1155\/2013\/482691","article-title":"Clinical differences between men and women with psoriatic arthritis: relevance of the analysis of genes and polymorphisms in the major histocompatibility complex region and of the age at onset of psoriasis","volume":"2013","author":"Queiro","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2018.11.007_bb0340","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/14397595.2016.1193105","article-title":"Gender specific differences in patients with psoriatic arthritis","volume":"27","author":"Nas","year":"2017","journal-title":"Modern Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0345","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10067-014-2652-9","article-title":"Extra-articular manifestations in psoriatic arthritis patients","volume":"34","author":"Peluso","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0350","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/rheumatology\/ket433","article-title":"Body weight, gender and response to TNF-\u03b1 blockers in axial spondyloarthritis","volume":"53","author":"Gremese","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2018.11.007_bb0355","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s10067-017-3769-4","article-title":"A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors","volume":"36","author":"Chimenti","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0360","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.semarthrit.2017.01.002","article-title":"Psoriatic arthritis disease activity during pregnancy and the first-year postpartum","volume":"46","author":"Polachek","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0365","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archderm.141.5.601","article-title":"Hormonal effect on psoriasis in pregnancy and postpartum","volume":"141","author":"Murase","year":"2005","journal-title":"Arch Dermal"},{"key":"10.1016\/j.autrev.2018.11.007_bb0370","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-4362.1996.tb01632.x","article-title":"Psoriasis and pregnancy: hormone and immune system interaction","volume":"35","author":"Boyd","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0375","first-page":"257","article-title":"Hormonal influences on women with psoriasis","volume":"61","author":"Mowad","year":"1998","journal-title":"Cutis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0380","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.berh.2016.10.007","article-title":"The eye and inflammatory rheumatic diseases: the eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis","volume":"30","author":"Murray","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0385","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaad.2010.10.032","article-title":"Ocular psoriasis","volume":"65","author":"Rehal","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0390","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ard.35.4.354","article-title":"Eye inflammation in psoriatic arthritis","volume":"35","author":"Lambert","year":"1976","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0395","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10067-015-2960-8","article-title":"Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease","volume":"34","author":"Rosenbaum","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0400","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.59.1.67","article-title":"Characterisation of uveitis in patients with psoriatic arthritis","volume":"59","author":"Paiva","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0405","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/bjd.12731","article-title":"Psoriasis and uveitis: should we be asking about eye symptoms?","volume":"170","author":"Burden-Teh","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0410","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/ICU.0000000000000098","article-title":"Ocular manifestations of seronegative spondyloarthropathies","volume":"25","author":"Zagora","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0415","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/09273948.2010.542269","article-title":"What is new HLA-B27 acute anterior uveitis?","volume":"19","author":"Wakefield","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.autrev.2018.11.007_bb0420","series-title":"Handbook of systemic autoimmune diseases","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/B978-0-12-803997-7.00016-8","article-title":"Cardiovascular involvement in psoriatic arthritis","volume":"14","author":"Atzeni","year":"2017"},{"key":"10.1016\/j.autrev.2018.11.007_bb0425","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00296-017-3895-y","article-title":"Addressing comorbidities in psoriatic disease","volume":"38","author":"Patel","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2018.11.007_bb0430","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.autrev.2011.05.022","article-title":"Atherosclerosis in psoriatic arthritis","volume":"10","author":"Ramonda","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0435","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.rdc.2015.07.008","article-title":"Comorbidities in psoriatic arthritis","volume":"41","author":"Husni","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2018.11.007_bb0440","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/ard.2008.094839","article-title":"Cardiovascular morbidity in psoriatic arthritis","volume":"68","author":"Gladman","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0445","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/art.1780401021","article-title":"Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death","volume":"40","author":"Wong","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0450","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N","article-title":"Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death","volume":"41","author":"Gladman","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0455","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/art.40389","article-title":"Higher coronary plaque burden in psoriatic arthritis is independent of metabolic syndrome and associated with underlying disease severity","volume":"70","author":"Szentpetery","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0460","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1574887113666180314105511","article-title":"On behalf of CaRRDs study group L. cardiovascular risk markers and major adverse cardiovascular events in psoriatic arthritis patients","volume":"13","author":"Peluso","year":"2018","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.autrev.2018.11.007_bb0465","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/annrheumdis-2015-207980","article-title":"Incidence and predictors for cardiovascular events in patients with psoriatic arthritis","volume":"75","author":"Eder","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0470","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.semarthrit.2005.12.002","article-title":"Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"35","author":"Gonzalez-Juanatey","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0475","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.atherosclerosis.2018.03.004","article-title":"Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: association with vitamin D and inflammation","volume":"271","author":"Lo Gullo","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0480","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","article-title":"Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis","volume":"36","author":"Kimhi","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0485","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.22884","article-title":"High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0490","first-page":"877","article-title":"Subclinical atherosclerosis in psoriatic arthritis: a case-control study","volume":"35","author":"Eder","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0495","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/acr.22144","article-title":"Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis","volume":"66","author":"Lin","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2018.11.007_bb0500","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.22530","article-title":"Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.11.007_bb0505","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10067-011-1892-1","article-title":"Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study","volume":"31","author":"Costa","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0510","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/rheumatology\/kes213","article-title":"Increase in ventricular-arterial stiffness in patients with psoriatic arthritis","volume":"51","author":"Shang","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.11.007_bb0515","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3899\/jrheum.140021","article-title":"High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease","volume":"41","author":"Haroon","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0520","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/ken090","article-title":"Cardiovascular risk profile of patients with psoriatic arthritis compared to controls\u2014the role of inflammation","volume":"47","author":"Tam","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.11.007_bb0525","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3899\/jrheum.111244","article-title":"Comorbidities of psoriatic arthritis \u2014 metabolic syndrome and prevention: a report from the GRAPPA 2010 annual meeting","volume":"39","author":"Raychaudhuri","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0530","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11154-016-9381-0","article-title":"Adipokines in psoriasis: an important link between skin inflammation and metabolic alterations","volume":"17","author":"Wolk","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.autrev.2018.11.007_bb0535","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/RHU.0000000000000721","article-title":"Increased prevalence of metabolic syndrome and adipocytokine levels in a psoriatic arthritis cohort","volume":"24","author":"Feld","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0540","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10067-017-3975-0","article-title":"Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study","volume":"37","author":"Caso","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0545","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12026-014-8595-z","article-title":"Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study","volume":"61","author":"Costa","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2018.11.007_bb0550","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10067-013-2369-1","article-title":"Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients","volume":"33","author":"Costa","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0555","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.autrev.2018.02.007","article-title":"Impact of obesity on autoimmune arthritis and its cardiovascular complications","volume":"17","author":"Van Raemdonck","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0560","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.autrev.2016.01.010","article-title":"Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy","volume":"15","author":"Iannone","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0565","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","article-title":"Obesity in autoimmune diseases: not a passive bystander","volume":"13","author":"Versini","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0570","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s10067-016-3344-4","article-title":"Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis","volume":"35","author":"Gentile","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0575","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0580","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1136\/annrheumdis-2012-202325","article-title":"Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity","volume":"72","author":"Eder","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0585","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1586\/1744666X.2016.1117941","article-title":"Progress in understanding and utilizing TNF-\u03b1 inhibition for the treatment of psoriatic arthritis","volume":"12","author":"Caso","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0590","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s10067-014-2603-5","article-title":"Efficacy of tocilizumab in a patient with refractory psoriatic arthritis","volume":"33","author":"Costa","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0595","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1517\/14728214.2016.1146679","article-title":"Emerging drugs for psoriatic arthritis","volume":"21","author":"Caso","year":"2016","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.autrev.2018.11.007_bb0600","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5114\/ada.2018.77665","article-title":"The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor \u03b1 in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis","volume":"35","author":"Pirowska","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"issue":"6","key":"10.1016\/j.autrev.2018.11.007_bb0605","doi-asserted-by":"crossref","first-page":"e1887","DOI":"10.1038\/cddis.2015.246","article-title":"The interplay between inflammation and metabolism in rheumatoid arthritis","volume":"17","author":"Chimenti","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.autrev.2018.11.007_bb0610","first-page":"1241","article-title":"Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms","volume":"27","author":"Scarpa","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0615","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1517\/14656566.2013.840292","article-title":"Psoriatic arthritis: advances in pharmacotherapy based on molecular target","volume":"14","author":"Scarpa","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.autrev.2018.11.007_bb0620","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaad.2006.12.003","article-title":"Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics","volume":"57","author":"Papoutsaki","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0625","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.berh.2018.08.012","article-title":"Gut inflammation in spondyloarthritis","volume":"31","author":"Rizzo","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0630","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/art.39649","article-title":"Interleukin-9 overexpression and Th9 polarization characterize the inflamed gut, the synovial tissue, and the peripheral blood of patients with psoriatic arthritis","volume":"68","author":"Ciccia","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.11.007_bb0635","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.autrev.2014.11.012","article-title":"T cell responses in psoriasis and psoriatic arthritis","volume":"14","author":"Diani","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0640","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2018.01.002","article-title":"Interaction between microbiome and host genetics in psoriatic arthritis","volume":"17","author":"Chimenti","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.11.007_bb0645","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.reuma.2010.03.003","article-title":"Prevalence of symptoms of anxiety and depression in patients with psoriatic arthritis attending rheumatology clinics","volume":"7","author":"Freire","year":"2011","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.autrev.2018.11.007_bb0650","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1196\/annals.1351.018","article-title":"Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels","volume":"1069","author":"Bruni","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2018.11.007_bb0655","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jpsychores.2012.08.008","article-title":"Alexithymia and emotional awareness in females with painful rheumatic conditions","volume":"73","author":"Baeza-Velasco","year":"2012","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.autrev.2018.11.007_bb0660","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.cell.2015.11.023","article-title":"Neuroinflammatory TNF impairs memory via astrocyte signaling","volume":"163","author":"Habbas","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2018.11.007_bb0665","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejim.2011.06.006","article-title":"Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications","volume":"22","author":"El Maghraoui","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2018.11.007_bb0670","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1183\/09059180.00001210","article-title":"Multiple pulmonary nodules in a male with psoriatic arthritis","volume":"116","author":"Manuel","year":"2010","journal-title":"Eur Respir Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:14:32Z","timestamp":1761599672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997219300850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":134,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1568997219300850"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.11.007","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}